Scarica l'app Stockscreener
104.00
0.29%
0.3673
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$103.63
Aprire:
$103.16
Volume 24 ore:
190.88K
Relative Volume:
0.12
Capitalizzazione di mercato:
$20.63B
Reddito:
$7.60B
Utile/perdita netta:
$1.08B
Rapporto P/E:
19.77
EPS:
5.26
Flusso di cassa netto:
$1.26B
1 W Prestazione:
+3.39%
1M Prestazione:
-5.96%
6M Prestazione:
-7.31%
1 anno Prestazione:
-19.03%
Intervallo 1D:
$102.86
$104.78
Intervallo di 1 settimana:
$99.43
$104.78
Portata 52W:
$97.69
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
103.93 | 20.63B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
134.34 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.33 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
385.51 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.67 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.98 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Weil Advises Underwriters on Zimmer Biomet’s $1.75 Billion Notes Offering - Weil, Gotshal & Manges LLP
Zimmer Biomet issues new notes, details merger agreement terms - Investing.com
Zimmer Biomet issues new notes, details merger agreement terms By Investing.com - Investing.com UK
This Zimmer Biomet Holdings Insider Reduced Their Stake By 71% - Simply Wall St
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Hourglass Capital LLC Has $7.12 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink? - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, market expansion - Investing.com Nigeria
Zimmer Biomet enters a distribution agreement with Promamec in Morocco - ZAWYA
Rhumbline Advisers Reduces Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock Hurt by Margin Concerns and Difficult Solvency - Yahoo Finance
AlphaCentric Advisors LLC Makes New $623,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
74,083 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by KLCM Advisors Inc. - MarketBeat
Legacy Capital Wealth Partners LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Chevy Chase Trust Holdings LLC Trims Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New York State Teachers Retirement System Has $17.82 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
MFG Wealth Management Inc. Acquires Shares of 14,259 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet price target lowered to $111 from $122 at Bernstein - MSN
Van ECK Associates Corp Buys 218,688 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
4,201 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Roman Butler Fullerton & Co. - MarketBeat
103,508 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Strategic Financial Concepts LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Hits New 12-Month LowTime to Sell? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
State of Alaska Department of Revenue Sells 6,280 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 22,396 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Barclays Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $112.00 - MarketBeat
Brokers Set Expectations for Zimmer Biomet Q1 Earnings - MarketBeat
Zimmer Biomet's (ZBH) Hold Rating Reaffirmed at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Lifted by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Paragon 28 : Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 - Marketscreener.com
Biomaterial Coating Market Expected to Hit by 2032 | Emerging Technologies & Growth Analysis | Royal DSM, - EIN News
Live Oak Private Wealth LLC Decreases Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Orthopedic Implants Market worth $26.47 billion by 2029 -February 11, 2025 at 04:02 am EST - Marketscreener.com
Zimmer Biomet (NYSE:ZBH) Receives Hold Rating from Needham & Company LLC - MarketBeat
Orthopedic Implants Market worth $26.47 billion by 2029 - The Globe and Mail
Zimmer Biomet Holdings Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Zimmer Biomet (NYSE:ZBH) Shares Gap DownTime to Sell? - MarketBeat
Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript - MSN
Zimmer Biomet (NYSE:ZBH) Issues FY 2025 Earnings Guidance - MarketBeat
Zimmer Biomet projects 3%-5% revenue growth for 2025 with over 50 product launches in 36 months - MSN
Zimmer Biomet net sales increase 4.3% to USD 2.023 bn in Q4 2024 - Medical Buyer
Zimmer Biomet slips as outlook misses consensus - MSN
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates - MSN
Zimmer Biomet’s Strategic Growth Amid Challenges - TipRanks
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.09%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):